Pharmacoeconomics of empirical antifungal use in febrile neutropenic hematological malignancy and hematopoietic stem cell transplant patients
Stuart J Turner, Sharon CA Chen, Monica A Slavin, David CM Kong
Expert Review of Pharmacoeconomics & Outcomes Research | TAYLOR & FRANCIS LTD | Published : 2013
SCA Chen and MA Slavin have sat on advisory boards for and received research funding (unrelated to this work) from Pfizer, Merck, Schering-Plough and Gilead Sciences. DCM Kong has sat on the advisory board for Pfizer and received financial support (not related to the current work) from Pfizer, Merck and Gilead Sciences. The authors have no other relevant affiliations or financial involvement with any organization or entity with a financial interest in or financial conflict with the subject matter or materials discussed in the manuscript apart from those disclosed.